Demographic, clinical and management characteristics of newly diagnosed COPD patients in Turkey: A real-life study

Basit Öğe Kaydı
dc.authorid0000-0002-1000-7818
dc.authorid0000-0003-4881-3097
dc.authorid0000-0002-5236-766X
dc.authorid0000-0001-5953-4881
dc.contributor.authorSüerdem, Mecit
dc.contributor.authorGünen, Hakan
dc.contributor.authorAkyıldız, Levent
dc.contributor.authorÇilli, Aykut
dc.contributor.authorÖzlü, Tevfik
dc.contributor.authorUzaslan, Esra
dc.contributor.authorAbadoğlu, Öznur
dc.contributor.authorBayram, Hasan
dc.contributor.authorÇımrın, Arif Hikmet
dc.contributor.authorGemicioğlu, Bilun
dc.contributor.authorMısırlıgil, Zeynep
dc.date.accessioned2020-03-26T20:20:12Z
dc.date.available2020-03-26T20:20:12Z
dc.date.issued2020
dc.departmentSelçuk Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractPurpose: In order to determine the clinical and sociodemographic characteristics of newly diagnosed treatment-naive asthma and COPD patients in Turkey, a multicenter study in 2012 was initiated. We aimed to investigate the characteristics and therapies of COPD patients in the original study in more detail. Patients and Methods: This nation-wide, multicentric, non-interventional, prospective, real-life observational cohort study was conducted in 122 centers. The newly diagnosed patients were not receiving any treatment before the recruitment. Their general characteristics, the combined GOLD 2011 COPD categories and exacerbation histories were noted. The patients were followed up with 3 voluntary visits for 1 year. Their adherence to the inhaled treatment according to GOLD 2011 was evaluated during follow-up visits. Results: The study included 776 COPD patients. Their mean age was 59.4 +/- 9.1 years, and 11.9% of the patients were female. 35.1% of the patientswere in the GOLD 2011 C and D category. 12.6% are frequent exacerbators, and 52.8% had at least one comorbid condition. 71.8% overtreatment rate was detected. Their attendance rates for three follow-up visits became 55.9%, 32.9% and 18.7%, respectively. The adherence rate to the treatment was measured as 81.9%. Conclusion: Although these patients were diagnosed for the first time, the GOLD C and D categories and frequent exacerbator phenotype were found at a high rate. They were usually prescribed an overtreatment regimen. We think that newly diagnosed COPD patients should be evaluated carefully, and best effort should be made to treat these patients in accordance with the recommendations of the major COPD guidelines.en_US
dc.description.sponsorshipAbdi Ibrahim Ilac San. ve Tic. AS, Turkey; Abdi Ibrahim; Sanofi; AstraZenecaAstraZeneca; NovartisNovartis; Devaen_US
dc.description.sponsorshipThe study is financially supported by "Abdi Ibrahim Ilac San. ve Tic. AS, Turkey." All authors are members of the advisory board of the study and received payment from "Abdi Ibrahim Ilac San. ve Tic. AS, Turkey" for this. Professor Hakan Gunen reports non-financial support from AbdiIbrahim Pharmaceutical Company, during the conduct of the study; AbdiIbrahim Turkey Pharmaceutical Company paid the publication processing fee, outside the submitted work. Dr Tevfik Ozlu reports personal fees from Abdiibrahim, during the conduct of the study; Prof. Dr. Oznur Abadoglu reports grants from Abdi Ibrahim, during the conduct of the study. Dr Bilun Gemicioglu reports Clinical research grants from Sanofi, AstraZeneca, Novartis; Consultancy or lecture grants from Abdi Ibrahim, Deva, Novartis, during the conduct of the study. Prof. Dr. Zeynep Misirligil report grants, personal fees from Abdi Ibrahim Ilac San. ve Tic. AS, during the conduct of the study. The authors report no other conflicts of interest in this work.en_US
dc.identifier.citationSuerdem, M., Gunen, H., Akyildiz, L., Cilli, A., Ozlu, T., Uzaslan, E., Abadoglu, O., Bayram, H., Cimrin, A. H., Gemicioglu, B., Misirligil, Z. (2020). Demographic, Clinical and Management Characteristics of Newly Diagnosed COPD Patients in Turkey: A Real-Life Study. International Journal of Chronic Obstructive Pulmonary Disease, 15, 261-267.
dc.identifier.doi10.2147/COPD.S211838en_US
dc.identifier.endpage267en_US
dc.identifier.issn1178-2005en_US
dc.identifier.pmid32103925en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage261en_US
dc.identifier.urihttps://dx.doi.org/10.2147/COPD.S211838
dc.identifier.urihttps://hdl.handle.net/20.500.12395/38527
dc.identifier.volume15en_US
dc.identifier.wosWOS:000515242300001en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorSüerdem, Mecit
dc.language.isoenen_US
dc.publisherDOVE MEDICAL PRESS LTDen_US
dc.relation.ispartofINTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASEen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectCOPDen_US
dc.subjectnewly diagnoseden_US
dc.subjecttreatment naiveen_US
dc.subjectexacerbationsen_US
dc.titleDemographic, clinical and management characteristics of newly diagnosed COPD patients in Turkey: A real-life studyen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Mecit SUERDEM.pdf
Boyut:
908.33 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Full Text Access
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Göğüs Hastalıkları/Makale Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu